Rating
Buy
Price target
$240
Previous
$200
Implied upside
+21%

BofA Securities analyst Vivek Arya raised the price target on Marvell Technology (NASDAQ: MRVL) to $240.00 (from $200.00) while maintaining a Buy rating.

“We reiterate our Buy on top compute pick MRVL.

Its unique accelerating growth franchise arguably has the broadest breadth of premium IP across compute, CPU, accelerators/LPU, networking, optics/CPO, memory/storage (incl. emerging CXL standard) and security.

The company beat/raised again, with FY27/FY28E (roughly CY26/27E) sales raised to $11.5bn/$16.5bn from $11bn/$15bn prior, as optics business continues to surge.

The company also offered a high-level outlook for FY29 with custom compute going to $10bn from $4bn YoY.

Overall we raise FY27/28/29E pf-EPS by +6%/+9%/+29% to $4.06/$6.11/$10.02, which represents an accelerating EPS growth rate. Our model suggests MRVL’s pf-EPS could 2.5x by CY28 and nearly 4x by CY30.

Key risks are the lumpiness and competitive nature of custom programs. We raise our PO to $240 from $200 based on unchanged 30x FY29/CY28E PE (incl. SBC).

Closest comp AMD is trading at a 2-3x turn premium, so there could be headroom for multiple expansion as MRVL executes on its custom programs and maintains/expands share in compute/connectivity.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.